Did management answer the analysts?
12 analyst questions audited, 3 evaded or deflected.
View Claim Ledger →Coromandel International reported Q4 FY26 consolidated revenue of ₹6,680 crore (+19% YoY) and EBITDA of ₹494 crore (+16% YoY), driven by record fertilizer sales of 4.3 million tons (+7% YoY) and strong crop protection growth.
✓ Verified against BSE filing
Coromandel International reported Q4 FY26 consolidated revenue of ₹6,680 crore (+19% YoY) and EBITDA of ₹494 crore (+16% YoY), driven by record fertilizer sales of 4.3 million tons (+7% YoY) and strong crop protection growth. PAT fell to ₹115 crore (vs ₹578 crore) due to exceptional items: prior-year land sale gain of ₹347 crore and current-year impairment of ₹71 crore in the drone business. Full-year revenue hit a record ₹31,827 crore (+30% YoY) with EBITDA of ₹3,232 crore (+23% YoY). The fertilizer segment faced margin compression from surging raw material costs (ammonia ~$840/ton, sulfur ~$800/ton) not fully covered by subsidy. Management expects government relief but declined margin guidance. Crop protection standalone EBITDA margin improved to ~19%. Key risk: delayed subsidy pass-through could pressure H1 FY27 margins.
12 analyst questions audited, 3 evaded or deflected.
View Claim Ledger →0 delivered, 0 close, 1 missed.
View Promises →Raw material price spike and subsidy gap
View Risks →Full transcript text is available on this route.
Read Transcript →Record sales of DAP and NPK; market share in phosphatic sector reached 17.5%.
Market leader in nano DAP with ~50% share; strong adoption amid rising conventional fertilizer prices.
Record revenue driven by export volume growth and new product introductions (10 new products, 21% of revenue).
Added 300+ new stores; expanded into Maharashtra and Tamil Nadu.
NACL integration and product portfolio changes expected to improve margins from current 6-7%.
Project to expand granulation capacity is on track for commissioning by December of this financial year.
Planned volume increase from 3.5 lakh tons to support backward integration.
Driven by new product launches (6 new products), capacity expansion for key molecule, and aggressive domestic formulation growth.
Management reiterated the annualized EBITDA margin target of ₹5,000-5,500 per ton for the fertilizer business, despite near-term pressure from higher sulfur prices and currency depreciation.
The sulfuric acid and phosphoric acid plants at Kakinada are progressing as per timelines and will be commissioned during Q4 FY26.
The granulation train expansion is on track and will be commissioned in the third quarter of FY27.
Ammonia and sulfur prices surged ~$840/ton and ~$800/ton respectively, while NBS rates increased only 10%. Government may not provide timely additional subsidy, compressing H1 margins.
80%+ of ammonia and sulfur imports transit via the Strait of Hormuz; ongoing crisis threatens Q2 availability and keeps prices elevated.
₹71 crore impairment taken on Daksha investment due to order execution delays; management is personally driving recovery but no near-term revenue visibility.
Despite 60% volume growth, adoption remains slow without policy intervention; farmers continue to prefer subsidized urea and DAP.
Sulfur prices have surged to $550/ton from $180-200, impacting input costs. Management expects moderation but uncertainty remains.
Current NBS rates may not fully compensate for higher raw material costs and rupee depreciation, pressuring fertilizer margins.
NCL's margins remain muted due to lower capacity utilization at hedge facilities; full synergy benefits may take longer.
Consumption-based market share moderated to 14% in Q3 from 15% last year due to lower offtake in southern states.
Mentioned in Q2 FY26, Q3 FY26
NCL's margins remain muted due to lower capacity utilization at hedge facilities; full synergy benefits may take longer.
Driven by new product launches (6 new products), capacity expansion for key molecule, and aggressive domestic formulation growth.
Ammonia and sulfur prices surged ~$840/ton and ~$800/ton respectively, while NBS rates increased only 10%.
View Risks →